Risk of Iodine Deficiency in Extremely Low Gestational Age Newborns on Parenteral Nutrition

Neelakanta Kanike1, Sharon Groh-Wargo1, Megan Thomas2

  • 1Department of Pediatrics, Division of Neonatology, Case Western Reserve University, Metro Health Medical Center, Rm C.G75, 2500 MetroHealth Drive, Cleveland, OH 44109, USA.

Nutrients
|June 5, 2020
PubMed

Insights

Iodine deficiency is common in pregnant women and extremely low gestational age newborns (ELGAN). ELGAN on parenteral nutrition (PN) are at risk for hypothyroidism, highlighting the need for iodine supplementation.

Area of Science:

  • Endocrinology
  • Neonatology
  • Nutritional Science

Background:

  • Iodine is essential for thyroid hormone synthesis, crucial for neurodevelopment.
  • Routine iodine status assessment is lacking in pregnant women and newborns.
  • Extremely Low Gestational Age Newborns (ELGAN) on parenteral nutrition (PN) do not receive iodine supplementation.

Purpose of the Study:

  • To assess iodine status and thyroid function in mother-infant dyads.
  • To evaluate iodine levels in breast milk and PN.
  • To correlate iodine status with thyroid function in ELGAN.

Main Methods:

  • Measured urine iodine and thyroid function tests (free T4, TSH, thyroglobulin) in 50 mother-infant dyads.
  • Sampled at birth, 1 week, 1, 2, 3 months, and near discharge.
  • Analyzed iodine content in milk and PN; correlated maternal/neonatal iodine with thyroid function.

Main Results:

  • 64% of mothers were iodine deficient at delivery; ELGAN showed transiently high iodine levels post-exposure.
  • ELGAN on PN developed iodine deficiency and elevated thyroglobulin by 1 month.
  • Iodine levels improved with enteral feeding by 2 months; PN-exposed ELGAN had significantly higher iodine than full-term infants.

Conclusions:

  • Iodine deficiency is prevalent in pregnant women and ELGAN.
  • ELGAN on PN are at high risk for iodine deficiency and subsequent hypothyroidism.
  • Consideration of iodine supplementation during pregnancy and postnatally is recommended.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
551
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
934
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
171
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
164
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
189
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K